Australia still prone to “radical” shortages post-pandemic

GBMA’s Jane Halton says pandemic lesson is pricing, lack of market influence and geography still leave Australia’s medicines supply vulnerable A senior pharma industry leader has warned Australia is still vulnerable to serious stock shortages and needs to remember the health security lessons learnt from the pandemic. Speaking at the APP2023’s State Of The Industry

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The week in review
Next Your daily dose of APP2023: day three